Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Washington University School of Medicine
GlaxoSmithKline
Nanfang Hospital, Southern Medical University
Incyte Corporation
Stanford University
Thomas Jefferson University
Incyte Corporation
Eilean Therapeutics
Eilean Therapeutics
National Cancer Institute (NCI)
University of Alabama at Birmingham
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
University of Turin, Italy
Ohio State University Comprehensive Cancer Center
Incyte Corporation
Incyte Corporation
University of Rochester
Merck Sharp & Dohme LLC
Incyte Corporation
M.D. Anderson Cancer Center
Prelude Therapeutics
iOnctura
University of Southern California
City of Hope Medical Center